GL1X · GenesisL1 explorer

MolNFT v1 · #157422 · protein

Crystal structure of hemagglutinin from influenza virus A/PHILLIPINES/2/1982 (H3N2)

6MYM: “Crystal structure of hemagglutinin from influenza virus A/PHILLIPINES/2/1982 (H3N2)”. X-ray diffraction, 2 ligands (NAG, BMA), 20 pockets (best druggability 0.84). MolNFT v1 #157422 on GenesisL1: 3D structure, binding sites and…

PDB
6MYM
Type
protein
Length
1,459 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hemagglutinin
UniProt
D8KS88
Ligands
NAG, BMA
Pockets
20 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHemagglutininprotein48626% helix, 31% strandD8KS88
CHemagglutininprotein48726% helix, 30% strandD8KS88

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 36 copies · chains A, C, B
  • BMA · beta-D-mannopyranose · sugar · 7 copies · chains C, A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 10 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16360.840.8855empty
211460.740.77116empty
32550.730.8733empty
46600.720.7962empty
56270.710.7965empty

Interfaces

3 interfaces between chains.

  • A–B · 2420 Ų buried · 33 hydrogen bonds · protein-protein
  • A–C · 2353 Ų buried · 29 hydrogen bonds · protein-protein
  • B–C · 2288 Ų buried · 24 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 22 glycan, 15 disulfide (N-glycosylation, disulfide).

Compared structures

  • 6MYM · Crystal structure of hemagglutinin from influenza virus A/Phillipines/2/1982 (H3N2) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.